There are numerous innovations on the mhealth platforms to cater for people suffering from diabetes. There is a considerably high number of people who are suffering from diabetes in the world. Scientists have taken initiative in coming up with a lot innovative mhealth ways to tailor make solutions for people with diabetes since it is considered a long-term complication. This is done by using their smartphones to self-manage and care for people suffering from diabetes.
What consists of the mhealth structure on diabetes management?
The patient has to have access to a smartphone equipped with a special diabetes app connected to a blood glucose meter. This will be useful for tracking and storing the patients daily blood glucose data and status on their mhealth platforms.
The acquired data on the blood glucose is then transmitted and stored in a remote portal hosted in a health facility for example a hospital or a clinic. Artificial intelligence then processes the data and produce simple illustrative graphics which can be accessed by both the physician and patient.
The mhealth platform adapts the diabetes medication and the treatment plan required for each of the patients. Such information is based on their self-management history, daily blood glucose profiles, treatment progress together with their therapy protocol; plans accessed regularlyhttps://care.diabetesjournals.org/content/43/1/250
How mhealth has empowered people with diabetes?
People with diabetes can use mhealth innovations to self-monitor their blood glucose and any other variables when needed which may include blood pressure their weight and even their diet
Mhealth helps people suffering from diabetes to engage in their own self-management by urging them to be self-sufficient. This is also seen when it allows patients and their physicians interaction through the various platforms provided. This in return potentially brings down the cost of diabetes treatment.
Mhealth platform offers a platform provides an interactive platform where feedback between patients and their physicians set and achieve pre-set care targets with regards to the diabetes condition progress and adherence to therapy https://mhealth.jmir.org/2019/1/e10321/.
How effective are the mhealth services on diabetes management?
There have been numerous studies conducted on this particular subject in the past few years. The reports indicate that the mhealth applications have had a positive impact on the targeted health behaviors and clinical outcomes. In addition to such reports there are others that report a high participants satisfaction. This was attributed to the fact that the mhealth applications can also enable earlier detection of other underlying conditions while still providing a technologically assisted decision making to the patienthttps://www.researchgate.net/publication/314089823_Diabetes_mHealth_Apps_Can_they_be_effective .
How are mhealth applications for diabetes regulated?
There are bodies mandated with regulating the operation of this applications.an example is the Food And Drug Administration. It evaluates how effective such applications are.
What barriers hinder the rigorous evaluation pf mhealth apps that cater for diabetes?
Mhealth platform is said to have a mismatch with health intervention evaluators.
Mhealth application creators work in fast paced environments where the consistent stream of data and testing leads to faster innovation of things. On the other hand, health evaluators are entrenched in the culture of academic research where evidence can take years to generate and release to the public. This in essence means that it takes a long time to design, more time to get funding, get approvals and even find volunteers on who a clinical trial can be conducted on https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426799/#:~:text=For%20patients%2C%20the%20main%20barriers,recommendation%20of%20apps%20by%20doctors..
Mhealth platforms face unnecessary evaluation which is an unnecessary business risk
Mhealth developers thrive on the uncertainty about whether their product will work. They assume that there is no risk of doing a study if their objective can be achieved without the rigorous evaluation. This approach makes it hard for a product to stand up to scientific scrutiny.
Mhealth evaluation is expensive.
Most of mhealth innovators are small start-app. They lack the resources to engage on things like rigorous evaluation. This is however bypassed by obtaining external funding. The funding goes a long way in commercializing the product after enough research has been conducted and development completedhttps://care.diabetesjournals.org/content/43/1/250